Objective:

To highlight the importance of early identification and management of poststroke spasticity to prevent disability and improve outcomes.

Approach:

Key Findings:

• 30% to 80% of stroke survivors experience spasticity, affecting millions in the US.
• Early intervention, especially within the first 3 months post-stroke, is crucial.
• Botulinum toxin shows strong evidence for reducing involuntary muscle activation.
• Current assessment methods are inadequate for distinguishing types of spasticity.

Interpretation:

Poststroke spasticity is a complex condition that can be effectively managed if identified early, potentially reducing long-term disability and healthcare costs.

Limitations:

• Limited randomized controlled trials on primary prevention.
• Current assessment tools may not accurately reflect the condition's complexity.

Conclusion:

Timely recognition and intervention for poststroke spasticity can significantly improve patient outcomes and reduce healthcare costs.

Sources:

• Stroke
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.